tradmap

BNGO Bionano Genomics, Inc.

$1.24 -2.76%

Updated

Healthcare · Laboratory Analytical Instruments

Bionano Genomics, Inc. (BNGO) is a healthcare company in the Laboratory Analytical Instruments industry, with a market capitalization of $15 million. Shares last traded at $1.24, 77.4% below their 52-week high. Over the past year the stock is down 68.2%. Net profit margin is -106.6%, below the peer median of -1.7%. Revenue declined 7.4% year over year.

Market Cap
$15M
Shares Out
11.8M
EPS (TTM)
$-10.22
P/E Ratio
P/S Ratio
0.48
P/B Ratio
0.46
Dividend / Share
Dividend Yield
52-Week High
$5.47
52-Week Low
$1.03
Volume
2,426
Avg Vol (3m)
2,580.635

Performance

1W
+1.23%
1M
+15.42%
3M
-1.98%
6M
+9.78%
YTD
-22.33%
1Y
-68.17%

Daily candles · volume · SMA(20)/SMA(50) · split-adjusted · Databento EQUS.MINI. BNGO split history →

Technicals

RSI (14)
56.19
SMA (50)
$1.16
SMA (200)
$1.28
Price vs SMA50
+6.39%
Price vs SMA200
-3.70%
ATR (14)
$0.05

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$30M
Net Income
$-32M
Gross Margin
47.5%
Operating Margin
-106.7%
Net Margin
-106.6%
Return on Equity
-101.8%
Return on Assets
-67.6%
Current Ratio
2.48
Debt / Equity
0.00
Revenue Growth (YoY)
-7.4%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 $-1.40 2026-08-10
Q1 2026 $-0.76 2026-05-13
FY 2025 $-4.85 2026-03-23
Q3 2025 $-4.82 2025-11-13
Q2 2026 $-3.24 2026-08-10
Q1 2026 $-1.15 2026-05-13

Full earnings history →

Laboratory Analytical Instruments peers

BNGO vs 14 industry peers (Laboratory Analytical Instruments), by market cap. Updated

P/S vs peers
0.48 / 5.01 med
-90% discount
Net margin vs peers
-106.6% / -1.7% med
below median
1–14 of 14
AAgilent Technologies$42.3B29.355.7319.5%-0.93%
WATWaters Corporation$40.6B63.248.7513.8%+0.36%
ILMNIllumina, Inc.$33.5B40.587.4518.4%+3.90%
MTDMettler Toledo$27.2B30.016.5821.9%-0.77%
RVTYRevvity$14.6B61.375.018.2%-0.24%
BIOBio-Rad Laboratories, Inc.$10.4B46.814.028.6%-0.19%
AVTRAvantor, Inc.$10.4B-18.811.58-8.4%+3.65%
BRKRBruker Corp$9.1B-127.122.59-2.0%+0.61%
TXG10x Genomics, Inc.$8.2B-108.5013.21-12.2%+2.45%
ALMRAlamar Biosciences, Inc.$2.1B+0.51%
CTKBCytek Biosciences, Inc.$611M-9.182.96-32.2%+0.21%
MASS908 Devices Inc.$414M-11.956.81-57.0%-3.05%
PACBPacific Biosciences Of California, Inc.$403M-3.06-1.52%
EYPTEyepoint, Inc.$394M-1.28-4.39%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.